Loading…
avatar for Ann Marie Trentacosti

Ann Marie Trentacosti

FDA
Medical Officer, Labeling Development Team, OND, CDER
Dr. Ann Marie Trentacosti is the Medical Lead for the Labeling Development Team (LDT) in the Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). LDT ensures that the prescribing information is a useful communication tool for health care providers, is based on regulations and guidance, and conveys the essential scientific information needed to prescribe and use drugs and biological products safely and effectively.

My Speakers Sessions

Tuesday, June 20
 

2:00pm CDT